Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
Lake Street Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3
Lake Street analyst Thomas Flaten maintains $Assertio(ASRT.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 44.1% and a
Assertio Therapeutics: Strong Buy Rating on Robust Portfolio and Strategic Growth
Assertio Therapeutics: A Strong Buy on Robust Financial Performance and Strategic Growth Potential
Assertio Holdings Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Assertio Therapeutics: A Strong Buy Amidst Robust ROLVEDON Growth and High Gross Margin Prospects